190 related articles for article (PubMed ID: 8176250)
21. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children.
Wiecker TS; Luther H; Buettner P; Bauer J; Garbe C
Cancer; 2003 Feb; 97(3):628-38. PubMed ID: 12548604
[TBL] [Abstract][Full Text] [Related]
22. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi.
Carli P; Biggeri A; Giannotti B
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):734-9. PubMed ID: 7722017
[TBL] [Abstract][Full Text] [Related]
23. Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study.
Fargnoli MC; Piccolo D; Altobelli E; Formicone F; Chimenti S; Peris K
Melanoma Res; 2004 Apr; 14(2):151-7. PubMed ID: 15057047
[TBL] [Abstract][Full Text] [Related]
24. Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in older patients (60 years and over).
Nagore E; Hueso L; Botella-Estrada R; Alfaro-Rubio A; Serna I; Guallar J; González I; Ribes I; Guillen C
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):50-7. PubMed ID: 19563496
[TBL] [Abstract][Full Text] [Related]
25. Are atypical nevi a risk factor for uveal melanoma? A case-control study.
van Hees CL; de Boer A; Jager MJ; Bleeker JC; Kakebeeke HM; Crijns MB; Vandenbroucke JP; Bergman W
J Invest Dermatol; 1994 Aug; 103(2):202-5. PubMed ID: 8040610
[TBL] [Abstract][Full Text] [Related]
26. Effect of neonatal phototherapy on melanocytic nevus count in children.
Matichard E; Le Hénanff A; Sanders A; Leguyadec J; Crickx B; Descamps V
Arch Dermatol; 2006 Dec; 142(12):1599-604. PubMed ID: 17178986
[TBL] [Abstract][Full Text] [Related]
27. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population.
Ródenas JM; Delgado-Rodríguez M; Herranz MT; Tercedor J; Serrano S
Cancer Causes Control; 1996 Mar; 7(2):275-83. PubMed ID: 8740740
[TBL] [Abstract][Full Text] [Related]
28. Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination.
Buettner PG; Garbe C
Am J Epidemiol; 2000 Jan; 151(1):72-7. PubMed ID: 10625176
[TBL] [Abstract][Full Text] [Related]
29. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
30. Markers and relative risk in a German population for developing malignant melanoma.
Garbe C; Krüger S; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
Int J Dermatol; 1989 Oct; 28(8):517-23. PubMed ID: 2583889
[TBL] [Abstract][Full Text] [Related]
31. Number of melanocytic nevi as a major risk factor for malignant melanoma.
Holly EA; Kelly JW; Shpall SN; Chiu SH
J Am Acad Dermatol; 1987 Sep; 17(3):459-68. PubMed ID: 3655025
[TBL] [Abstract][Full Text] [Related]
32. Relative frequency of solitary melanocytic lesions of the oral mucosa.
Buchner A; Merrell PW; Carpenter WM
J Oral Pathol Med; 2004 Oct; 33(9):550-7. PubMed ID: 15357676
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of melanocytic nevi and freckles in young Israeli males. Correlation with melanoma incidence in Jewish migrants: demographic and host factors.
Pavlotsky F; Azizi E; Gurvich R; Lusky A; Barell V; Weiner M; Iscovich J
Am J Epidemiol; 1997 Jul; 146(1):78-86. PubMed ID: 9215225
[TBL] [Abstract][Full Text] [Related]
34. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma.
Holman CD; Armstrong BK
J Natl Cancer Inst; 1984 Feb; 72(2):257-66. PubMed ID: 6582314
[TBL] [Abstract][Full Text] [Related]
35. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.
Chang YM; Newton-Bishop JA; Bishop DT; Armstrong BK; Bataille V; Bergman W; Berwick M; Bracci PM; Elwood JM; Ernstoff MS; Green AC; Gruis NA; Holly EA; Ingvar C; Kanetsky PA; Karagas MR; Le Marchand L; Mackie RM; Olsson H; Østerlind A; Rebbeck TR; Reich K; Sasieni P; Siskind V; Swerdlow AJ; Titus-Ernstoff L; Zens MS; Ziegler A; Barrett JH
Int J Cancer; 2009 Jan; 124(2):420-8. PubMed ID: 18792098
[TBL] [Abstract][Full Text] [Related]
36. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
Roush GC; Barnhill RL
Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
[TBL] [Abstract][Full Text] [Related]
37. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands.
Zaal LH; Mooi WJ; Klip H; van der Horst CM
Plast Reconstr Surg; 2005 Dec; 116(7):1902-9. PubMed ID: 16327602
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
39. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
Tucker MA; Halpern A; Holly EA; Hartge P; Elder DE; Sagebiel RW; Guerry D; Clark WH
JAMA; 1997 May; 277(18):1439-44. PubMed ID: 9145715
[TBL] [Abstract][Full Text] [Related]
40. The dysplastic nevus: recognition and management.
Barnhill RL; Hurwitz S; Duray PH; Arons MS
Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
